Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trials
CRO
FDA qualifies 1st AI drug development tool in MASH
AIM-NASH is meant to help score the different stages of liver biopsy, including fat infiltration, inflammation and scarring.
Gabrielle Masson
Dec 9, 2025 12:12pm
NIH cuts disrupted hundreds of clinical trials, study finds
Nov 17, 2025 11:00am
BMS boosts cancer trials with Sarah Cannon's platform
Nov 12, 2025 12:30pm
White House pledges $100M to AI pediatric cancer project
Oct 1, 2025 11:06am
One-third of data collected in trials may be unnecessary: study
Sep 19, 2025 11:01am
ABPI releases life sci competition report as UK investment lags
Sep 10, 2025 5:30pm
